ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy

Lung Cancer, 05/07/2012

Low expression of ERCC1 on circulating tumor cell correlates with Progression–free survival in patients with metastatic non–small–cell lung cancer receiving platinum–based therapy.

Print Article Summary Cat 2 CME Report